4//SEC Filing
Keller Rodney C. Jr. 4
Accession 0001493152-21-016125
CIK 0001086745other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 8:11 PM ET
Size
20.8 KB
Accession
0001493152-21-016125
Insider Transaction Report
Form 4
AYRO, Inc.AYRO
Keller Rodney C. Jr.
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2021-06-30$4.03/sh+13,977$56,327→ 448,144 total - Sale
Common Stock
2021-06-30$5.04/sh−13,977$70,394→ 434,167 total - Sale
Common Stock
2021-06-30$5.04/sh−426$2,146→ 434,167 total - Exercise/Conversion
Common Stock
2021-07-01$3.17/sh+70,000$221,900→ 504,167 total - Sale
Common Stock
2021-07-01$5.11/sh−70,000$357,700→ 434,167 total - Exercise/Conversion
Employee Stock Options (right to buy)
2021-06-30−13,977→ 0 totalExercise: $4.03Exp: 2029-11-13→ Common Stock (13,977 underlying) - Exercise/Conversion
Common Stock
2021-06-30$3.17/sh+426$1,350→ 434,593 total - Exercise/Conversion
Employee Stock Options (right to buy)
2021-06-30−426→ 459,042 totalExercise: $3.17Exp: 2030-09-29→ Common Stock (426 underlying) - Exercise/Conversion
Employee Stock Options (right to buy)
2021-07-01−70,000→ 389,042 totalExercise: $3.17Exp: 2030-09-29→ Common Stock (70,000 underlying)
Footnotes (7)
- [F1]Represents a broker-assisted sale of shares pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.15, inclusive. The reporting person undertakes to provide to AYRO, Inc., any security holder of AYRO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
- [F3]Represents an exercise of an option to purchase 13,977 shares. The price reported in Column 4 is the exercise price of the underlying options assigned upon grant.
- [F4]Represents an exercise of an option to purchase 426 shares. The price reported in Column 4 is the exercise price of the underlying options assigned upon grant.
- [F5]Represents an exercise of an option to purchase 70,000 shares. The price reported in Column 4 is the exercise price of the underlying options assigned upon grant.
- [F6]These options are fully vested and exercisable.
- [F7]The shares underlying this stock option vest according to the following schedule: one-third of the optioned shares vested on 12/4/2020, and an additional one-third of the optioned shares will vest on 12/4/2021 and 12/4/2022, respectively, provided that the reporting person has remained employed by or is providing services to the issuer through the applicable vesting date.
Documents
Issuer
AYRO, Inc.
CIK 0001086745
Entity typeother
Related Parties
1- filerCIK 0001813326
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 8:11 PM ET
- Size
- 20.8 KB